Reply  by Kappagoda, C. Tissa et al.
LH
I
o
c
C
d
p
b
t
a
c
f
w
s
b
i
(
c
b
b
C
i
e
n
a
m
h
I
g
i
h
p
a
f
r
t
n
r
t
n
t
t
c
o
Journal of the American College of Cardiology Vol. 44, No. 7, 2004
© 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00
Published by Elsevier Inc.ETTERS TO THE EDITOR
m
a
s
r
J
A
D
F
U
P
F
E
R
1
2
3
R
W
t
b
e
w
t
i
a
t
f
p
t
d
i
f
o
N
r
d
q
i
a
w
s
bigh-Protein Diets: Putting Rumors to Rest
“One could not be a successful scientist without realizing that, in
contrast to the popular conception supported by newspapers and
mothers of scientists, a goodly number of scientists are not only
narrow-minded and dull, but also just stupid.”
J. D. Watson, The Double Helix
read with great interest the study by Kappagoda et al. (1)
n high-protein diets. Unfortunately, they quoted uncriti-
ally the American Heart Association (AHA) Nutrition
ommittee’s statement on dietary protein and weight re-
uction, which states, “Individuals who follow these [high-
rotein] diets are at risk for . . . potential cardiac, renal,
one, and liver abnormalities overall.”
Liver abnormalities? That is physiological nonsense. Pro-
ein is needed not only to promote liver tissue repair, but
lso to provide lipotropic agents such as methionine and
holine for the conversion of fats to lipoprotein for removal
rom the liver, thus preventing fatty infiltration (2). And
hen it comes to kidney function, there are no data in the
cientific literature demonstrating that healthy kidneys will
e damaged by the increased demands of protein consumed
n quantities above the recommended dietary allowance
RDA) (2). Furthermore, real-world examples support this
ontention because kidney problems are nonexistent in the
odybuilding community in which high-protein intake has
een the norm for over half a century. The AHA Nutrition
ommittee also suggests that high-protein intake may
ncrease blood pressure. However, there is no scientific
vidence whatsoever supporting this contention. In fact, a
egative correlation has been shown between protein intake
nd systolic and diastolic blood pressures in several epide-
iological surveys (2).
Further, the AHA Nutrition Committee claims that
igh-protein intake has detrimental effects on bone health.
n reality, dietary protein increases circulating insulin-like
rowth factor (IGF)-1, a growth factor believed to play an
mportant role in bone formation. Indeed, several studies
ave examined the impact of protein supplementation in
atients with recent hip fractures. For example, Schurch et
l. (3) reported that supplementation with 20 g protein/day
or six months increased blood IGF levels and reduced the
ate of bone loss in the contralateral hip during the year after
he fracture. Finally, the AHA Nutrition Committee ig-
ores the fact that energy restriction increases protein
equirements. It has been known for about a half century
hat inadequate energy intake leads to increased protein
eeds (2). Thus, when trying to lose weight, it is important
o keep protein levels high. The reduction in calories needed
o lose weight should be at the expense of the fats and
arbohydrates, not protein.
In summary, the AHA Nutrition Committee’s statement
n dietary protein contains misleading and incorrect infor- bation. Certainly, such public warnings should be based on
thorough analysis of the scientific literature, not unsub-
tantiated fears and misrepresentations. For a more detailed
eview, see my recent paper in the Sports Nutrition Review
ournal (2).
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EPLY
e appreciate Dr. Manninen’s interest in our paper (1). In
he process of highlighting the issue of protein intake we
elieve he has raised the telescope to the Nelsonian blind
ye and ignored the main thrust of our position. Our focus
as high-protein–low-carbohydrate (Atkins type) diets in
he context of clinical cardiology. These diets invariably
nclude significant quantities of saturated fats, cholesterol,
nd sodium, and they are consistently low in fiber. These are
he areas of concern to those who are responsible for caring
or patients with cardiovascular disease. Bodybuilders are
robably estimable people, but they do not usually consti-
ute a large sector of our practice.
The issue of the actual amount of protein to be consumed
aily is a difficult one to resolve. Problems associated with
dentifying upper limits for protein intake have been covered
ully in the report issued by the Food and Nutrition Board
f the Institute of Medicine, which is a component of the
ational Academy of Sciences in the U.S. A detailed
eading of this report will provide some insights into
ifficulties in identifying these limits, and the Board has,
uite properly in our view, advocated prudence. The Amer-
can Heart Association (AHA) Nutrition Committee has
lso adopted a similar cautious approach. We are uncertain
hether the members of these bodies consulted the distaff
ides of their families in preparing their respective reports,
ut we are persuaded that they have indeed reviewed the
est available evidence in making their recommendations.
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echanism of a
ypertensive Response to Exercise
ottram et al. (1) recently reported in the Journal new and
nexpected findings: that a hypertensive response to exercise
systolic blood pressure 210 mm Hg in males and 190
m Hg in females) in normotensive and hypertensive
ubjects is associated with subtle defects in systolic left
entricular (LV) function. A number of possible mecha-
isms were proposed.
Another explanation, not canvassed, relates to the effects
f wave reflection on the pattern of systolic LV ejection, and
n amplification of the aortic pressure wave to the site of
ressure recording in the brachial artery.
Amplification of the pressure wave to the brachial or
adial artery can be substantial during exercise, with one
tudy showing peak difference of 80 mm Hg between aortic
nd radial peak pressure during maximal exercise (2). The
egree of amplification depends on ejection period, being
reatest when this is short, and least when it is long (3–5).
mplification of the pulse wave is attributable to wave
eflection within the upper limb (3–6).
Most wave reflection returning to the heart comes from
he lower part of the body (trunk and lower limbs) (6). This
ppears to be maintained during exercise in patients with
ystolic LV dysfunction (7). However, effects of wave
eflection on the heart depend on the ability of the heart to
ject against pressure. With impaired LV contractility,
eflection has a greater effect on flow than pressure (8), and
his restricts late ejection, causing shortened ejection, with
ccompanying decrease in stoke volume. The shortened
jection in severe heart failure is responsible for absence of
ystolic augmentation and appearance of the classic “di-
rotic” pulse waveform (6,9).
It is quite possible that this mechanism is responsible for
he findings of Mottram et al. (1), namely that increased
ave reflection during the challenge of exertion causes
reater reduction than usual in ejection duration, and that hhis leads to greater amplification of the pulse in the upper
imb, and a greater recorded systolic pressure in the upper
imb.
Finally, such a hypothesis could be tested by measuring
jection duration during exercise, and/or by estimating the
ortic systolic pressure from the upper limb waveform. Have
he investigators considered measuring ejection duration or
entral systolic pressure?
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e thank Dr. O’Rourke for his comments in response to
ur study. Our report demonstrated that sensitive new
yocardial measurements in normotensive patients who
ave a hypertensive response to exercise have abnormal left
entricular (LV) systolic and probably also diastolic behavior
1). We proposed that this phenomenon likely represents
ntrinsic damage to the myocardium, most probably from
hronic exposure to “high-normal” levels of systemic blood
ressure, which was present in these patients (1). Clearly,
istological examination of myocardial tissue for hyperten-
